AbbVie Inc. (NYSE:ABBV)

The period under review demonstrates significant fluctuations in economic profit. Initial years exhibited positive economic profit, followed by a period of negative economic profit, and a subsequent return to positive values. These shifts are influenced by changes in net operating profit after taxes, cost of capital, and invested capital.

Net Operating Profit After Taxes (NOPAT)

NOPAT experienced a decline from US$12,362 million in 2021 to US$11,543 million in 2022. A substantial decrease was then observed in 2023, falling to US$3,292 million. A recovery began in 2024, reaching US$4,563 million, and continued into 2025 with a further increase to US$5,919 million. This indicates a period of profitability challenges followed by a strengthening of operational performance.

Cost of Capital

The cost of capital consistently increased throughout the period, rising from 7.78% in 2021 to 8.65% in 2025. This steady increase in the cost of funding likely contributed to the pressure on economic profit, particularly when NOPAT was declining.

Invested Capital

Invested capital decreased from US$95,922 million in 2021 to US$82,134 million in 2022, and continued to decline to US$68,204 million in 2023. A slight increase to US$69,263 million occurred in 2024, but it subsequently decreased again to US$61,356 million in 2025. The reduction in invested capital may reflect strategic asset sales or reduced investment activity.

Economic Profit

Economic profit followed a distinct pattern. Positive economic profit of US$4,903 million was recorded in 2021, followed by US$4,726 million in 2022. A significant shift occurred in 2023, resulting in a negative economic profit of US$2,495 million. This negative trend continued in 2024 with a loss of US$1,347 million. However, economic profit returned to positive territory in 2025, reaching US$611 million. The fluctuations in economic profit are a direct result of the interplay between NOPAT, cost of capital, and invested capital. The return to positive economic profit in 2025 suggests improved capital allocation efficiency despite the higher cost of capital.

The observed trends suggest a period of operational and financial adjustments. While the increasing cost of capital presents an ongoing challenge, the recovery in NOPAT and the eventual return to positive economic profit in the final year indicate a potential stabilization and improvement in financial performance.

Net earnings attributable to AbbVie Inc. exhibited an initial increase from 2021 to 2022, followed by a substantial decline in 2023 and a slight recovery in 2024 and 2025. However, the trend in net operating profit after taxes (NOPAT) presents a different pattern. NOPAT decreased from 2021 to 2023, then increased significantly in 2024 and 2025.

NOPAT Trend

NOPAT began at US$12,362 million in 2021, decreasing to US$11,543 million in 2022, representing a decline of approximately 6.7%. A more pronounced decrease occurred in 2023, with NOPAT falling to US$3,292 million. This represents a substantial reduction of over 71% from the 2022 value. A recovery is then observed in 2024, with NOPAT rising to US$4,563 million, and continuing upward in 2025 to reach US$5,919 million. The 2025 value, while representing a significant improvement from 2023, remains below the levels seen in 2021 and 2022.

The divergence between the trends in net earnings and NOPAT suggests potential shifts in the company’s capital structure or non-operating items. While net earnings decreased significantly in 2023, the NOPAT decline was even more substantial, indicating that factors beyond core operating profitability contributed to the reduction in net income. The subsequent recovery in NOPAT, exceeding the recovery in net earnings, suggests improvements in operational efficiency or changes in the cost of capital may be influencing the results.

Relationship between NOPAT and Net Earnings

In 2021 and 2022, NOPAT was consistently higher than net earnings attributable to AbbVie Inc. However, this relationship changed in 2023 and 2024, where net earnings exceeded NOPAT. By 2025, net earnings and NOPAT were relatively close, but net earnings remained slightly higher. This difference could be attributed to items such as interest expense, taxes, and other non-operating income or expenses.

The substantial fluctuations in NOPAT warrant further investigation to understand the underlying drivers. A detailed analysis of the components of NOPAT, including operating revenue, operating expenses, and tax rates, would be necessary to pinpoint the specific factors contributing to these changes.

The reported income tax expense and cash operating taxes exhibit distinct trends over the five-year period. Income tax expense fluctuates considerably, while cash operating taxes generally increase, though with notable variations.

Income Tax Expense

Income tax expense increased from US$1,440 million in 2021 to US$1,632 million in 2022, representing a rise of approximately 13.3%. A subsequent decrease was observed in 2023, with expense falling to US$1,377 million. A significant shift occurred in 2024, resulting in a tax benefit of US$570 million. This was followed by a substantial increase in expense to US$2,364 million in 2025. The volatility suggests potential impacts from changes in tax laws, deferred tax asset adjustments, or significant shifts in pre-tax income.

Cash Operating Taxes

Cash operating taxes demonstrate an overall upward trend, although not consistently. The amount rose from US$2,843 million in 2021 to US$3,997 million in 2022, an increase of approximately 40.6%. Further growth was seen in 2023, reaching US$4,625 million. A considerable decline occurred in 2024, with cash taxes decreasing to US$1,339 million. The final year, 2025, shows a recovery to US$3,414 million. The fluctuations in cash taxes are likely influenced by timing differences between income tax expense and actual cash payments, as well as potential tax planning strategies.

Relationship between Income Tax Expense and Cash Operating Taxes

A divergence is apparent between the two measures. While income tax expense is reported on the income statement based on accounting standards, cash operating taxes reflect the actual cash outflows for taxes. The significant difference in 2024, where an income tax benefit is recorded alongside a cash outflow, indicates substantial deferred tax impacts or tax credits being utilized. The generally higher level of cash taxes compared to income tax expense throughout the period suggests the company may be utilizing tax loss carryforwards or experiencing temporary differences that result in higher cash payments than reported expense.

The observed patterns warrant further investigation into the underlying drivers of these fluctuations, particularly the significant changes in 2024 and 2025, to fully understand their implications for the company’s financial position and future cash flows.

The reported invested capital demonstrates a declining trend over the five-year period. Total reported debt & leases and stockholders’ equity both contribute to the calculation of invested capital, and changes in these components influence the overall trend.

Invested Capital Trend

Invested capital decreased from US$95,922 million in 2021 to US$61,356 million in 2025. The most significant decrease occurred between 2022 and 2023, falling from US$82,134 million to US$68,204 million. A smaller decrease was observed between 2021 and 2022. A slight increase occurred between 2023 and 2024, followed by a further decrease in 2025.

Debt & Leases

Total reported debt & leases decreased from US$77,575 million in 2021 to US$64,191 million in 2022, continuing to US$60,286 million in 2023. An increase to US$68,019 million was noted in 2024, followed by a marginal increase to US$68,379 million in 2025. While fluctuating, the level of debt remained relatively stable between 2024 and 2025.

Stockholders’ Equity

Stockholders’ equity increased from US$15,408 million in 2021 to US$17,254 million in 2022. However, a substantial decline was observed in subsequent years, decreasing to US$10,360 million in 2023, US$3,325 million in 2024, and ultimately reaching a deficit of US$-3,270 million in 2025. This negative equity position in the final year represents a significant shift.

The decrease in invested capital appears to be primarily driven by the substantial reduction in stockholders’ equity, particularly in the later years of the period. While debt levels decreased initially, they stabilized and even increased slightly in the most recent years, suggesting that debt reduction is not the primary driver of the overall decline in invested capital. The transition to negative stockholders’ equity in 2025 is a notable development that warrants further investigation.

The economic spread ratio exhibited considerable fluctuation over the five-year period. Initially positive, the ratio declined significantly, becoming negative before recovering in the final year. This movement correlates with changes in economic profit and invested capital.

Economic Spread Ratio Trend

The economic spread ratio began at 5.11% in 2021, increasing to a peak of 5.75% in 2022. A substantial decrease followed, with the ratio falling to -3.66% in 2023 and further to -1.94% in 2024. By 2025, the ratio had recovered to 1.00%, indicating a return to positive value creation relative to invested capital.

The economic spread ratio’s negative values in 2023 and 2024 suggest that the company’s returns on invested capital were below its cost of capital during those years. The recovery in 2025 indicates an improvement in this relationship, though the ratio remains relatively low compared to the initial years of the period.

Relationship to Economic Profit

The economic spread ratio’s trajectory closely mirrors that of economic profit. The decline in economic profit from US$4,903 million in 2021 to a loss of US$2,495 million in 2023 is reflected in the corresponding decrease in the economic spread ratio. The partial recovery of economic profit to US$611 million in 2025 aligns with the ratio’s return to positive territory.

Relationship to Invested Capital

Invested capital decreased consistently from US$95,922 million in 2021 to US$61,356 million in 2025. While decreasing invested capital can positively influence the economic spread ratio, this effect was initially overwhelmed by the significant decline in economic profit. The 2025 recovery in the ratio suggests that the reduction in invested capital contributed to the improved performance, alongside the increase in economic profit.

The observed volatility in the economic spread ratio warrants further investigation into the underlying drivers of economic profit and invested capital. Understanding the factors contributing to the negative spread in 2023 and 2024 is crucial for assessing the company’s long-term financial health.

The economic profit margin exhibited considerable fluctuation over the five-year period. Initially positive, it declined significantly before recovering towards the end of the analyzed timeframe. A detailed examination of the trends is presented below.

Economic Profit Margin Trend

In 2021, the economic profit margin stood at 8.72%. A slight decrease was observed in 2022, with the margin falling to 8.14%. However, 2023 marked a substantial shift, as the margin turned negative, reaching -4.59%. This negative trend continued into 2024, although at a lessened rate, with the margin reported at -2.39%. By 2025, the economic profit margin had begun to recover, increasing to 1.00%, indicating a return towards profitability.

Relationship to Net Revenues

Net revenues generally increased over the period, rising from US$56,197 million in 2021 to US$61,160 million in 2025. Despite this revenue growth, the economic profit margin did not consistently benefit. The decline in margin from 2021 to 2023 suggests that increases in costs or capital charges outpaced revenue gains during those years. The partial recovery in margin in 2025 coincides with a continued increase in net revenues, suggesting improved efficiency or cost management.

Economic Profit Fluctuations

Economic profit itself followed a similar pattern to the margin. Positive economic profit of US$4,903 million and US$4,726 million was reported in 2021 and 2022, respectively. A significant decline resulted in an economic loss of US$2,495 million in 2023, followed by a loss of US$1,347 million in 2024. The final year of the period showed a return to positive economic profit, albeit at a modest US$611 million.

The observed volatility in the economic profit margin warrants further investigation into the underlying drivers of profitability and capital efficiency. The shift from positive to negative economic profit, and the subsequent partial recovery, highlights the importance of monitoring both revenue generation and cost/capital management.